This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Increasing Participation in Pediatric Cancer Clinical Trials
Dr. Paula Aristizabal is Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology, Medical Director of the International Outreach Program, and Quality Improvement Lead at the University of California San Diego and Rady Children’s Hospital. Differences in pediatric cancer Dr. Aristizabal’s presentation covered the demographic shift in the US, differences in pediatric cancer, gaps in clinical trial participation in pediatric cancer research, challenges to clinical trial participation in Latinos, and strategies to improve recruitment of Latinos to clinical trials. The Latino population ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Residence in a Latino Enclave and Clinical Outcomes in Texas Children with Acute Lymphoblastic Leukemia
Dr. Jeremy Schraw is an Assistant Professor in the Division of Hematology-Oncology, Department of Pediatrics, at Baylor College of Medicine. Dr. Schraw began by pointing out the higher incidence of acute lymphoblastic leukemia (ALL) among Latino children, and the poorer overall survival (OS) following diagnosis. Non-medical drivers of health (NMDoH) likely contribute to these inconsistencies. In fact, children living in Latino enclaves, defined as neighborhoods with a high proportion of Latino residents, recent immigrants, and linguistically isolated households, have poorer OS after ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Task Force: Latino Researchers Against Cancer
This session occurred at 11:15 a.m., Friday, Feb. 23, 2024, at the 4th biennial Advancing the Science of Cancer in Latinos conference. Dr. Amelie Ramirez is Professor at the University of Texas (UT) San Antonio, Director of the Institute for Health Promotion Research, Chair of the Department of Population Health Sciences at UT Health San Antonio, and Associate Director of Cancer Outreach and Engagement at Mays Cancer Center. Dr. Ramirez’s presentation focused on communicating the mission and first year results of the Task Force: Latino Researchers Against Cancer (TFLRAC). The Task Force’s mission is to meet quarterly for 2 ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Integrating Clinical and Genomic Data for Tumor Molecular Profiling in Latino Patients with Cancer
Dr. Enrique I. Velazquez-Villarreal is Assistant Professor in the Department of Integrative Translational Sciences at Beckman Research Institute and the City of Hope Comprehensive Cancer Center. Multi-omics and colorectal cancer in Latinos Dr. Velazquez-Villarreal’s presentation discussed how multi-omics can be used to understand colorectal cancer gaps in Latino individuals and how global and local ancestry impacts these disparities. He also described clinical and genomic data integration in colorectal cancer gaps and recent technologies used to understand the tumor microenvironment. ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Non-Medical Drivers of Health Impacting Latino Cancer Health Gaps: Genetic Cancer Risk Assessment
Dr. Alejandra Hurtado de Mendoza is an Assistant Professor at the Cancer Prevention and Control Program at Georgetown Lombardi Comprehensive Cancer Center. Gaps across the continuum Dr. Hurtado de Mendoza’s presentation focused on gaps in genetic cancer risk assessment, multi-level hurdles that Latinos face across the genetic cancer risk assessment continuum, and an example of a multilevel intervention to decrease gaps. The presentation began by discussing how gaps in the genetic cancer risk assessment continuum begin with awareness. Only 23% of Latino individuals were aware of ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
The NCI Community Oncology Research Program: Opportunities to Increase Latino Participation in Clinical Trials
Dr. Brenda Adjei is Associate Director of the HDRP at the National Cancer Institute (NCI) Center for Cancer Research. The NCI Community Oncology Research Program Dr. Adjei’s presentation began with a discussion of Latino participation in cancer clinical trials. Variety in clinical trials is critically important because it generates biomedical knowledge relevant to all, builds trust and trustworthiness, and contributes to reductions in health gaps and fair research participation. Current limits in clinical research is due to multilevel hurdles and requires tailored, ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Conclusion
To eliminate gaps in cancer care in Latino populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient navigators, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing inequity. In the process, most of the speakers made recommendations, either specific to their field of study or more broadly. The following are some key recommendations abstracted from their conference ...
This content is from the "Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings."
Healthcare Gaps in the Latino Community
The Latino population both within and outside the US has significant heterogeneity. [Velazquez-Villarreal] After all, Latin America has been a melting pot of mixed populations for 500 years, with over 20 heritage groups recognized by the Hispanic Community Health Study/Study of Latinos. These groups are distinct, with unique backgrounds, language, and US influence, but are also connected by more similarities than differences. [Perez-Stable] Latino individuals are the largest and youngest overlooked community in the US and are projected to account for more than half of the overall growth through 2060. Compared to non-Hispanic White individuals, ...
Rheumatoid arthritis (RA) impacts some people more than others. In fact, about 70% of people living with RA are women, according to the World Health Organization. That makes it critical to promote education, resources, and support for women when it comes to treating and managing RA. With this in mind, you’re invited to watch “Thriving with RA: Essential Tips for Women’s Health and Wellness,” an online educational session that will empower women with RA to take control of their pain and health, helping them understand treatment options and know when and how to speak up to get the care they deserve. Join us to learn practical ways to improve pain, fatigue, and depression and find support tailored to you—because no one should have to face RA alone. Panelist Victoria ...
